Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
Urticarial vasculitis is characterised by inflamed itching or burning red patches or wheals that resemble urticaria but persist for greater than 24 hours. It is often idiopathic but is sometimes associated with collagen-vascular disease, particularly systemic lupus erythematosus. Treatment options i...
Saved in:
Main Authors: | Misbah Nasheela Ghazanfar (Author), Simon Francis Thomsen (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
by: Misbah Noshela Ghazanfar, et al.
Published: (2018) -
Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report
by: Yusuf Can Edek, et al.
Published: (2024) -
Urticarial Vasculitis of the Legs
by: I-Ting Lee, et al.
Published: (2019) -
Urticarial vasculitis as an initial manifestation of colonic carcinoma: a case report and review of the literature
by: A.A. Younis
Published: (2018) -
Urticarial vasculitis coexisting with primary myelofibrosis - a case report
by: Radomir Reszke, et al.
Published: (2017)